These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 16096728

  • 21. Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes.
    Burnier M, Zanchi A.
    J Hypertens; 2006 Jan; 24(1):11-25. PubMed ID: 16331093
    [Abstract] [Full Text] [Related]

  • 22. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Kujal P, Chábová VČ, Vernerová Z, Walkowska A, Kompanowska-Jezierska E, Sadowski J, Vaňourková Z, Husková Z, Opočenský M, Skaroupková P, Schejbalová S, Kramer HJ, Rakušan D, Malý J, Netuka I, Vaněčková I, Kopkan L, Cervenka L.
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
    [Abstract] [Full Text] [Related]

  • 23. Limitations of angiotensin inhibition.
    Nobakht N, Kamgar M, Rastogi A, Schrier RW.
    Nat Rev Nephrol; 2011 Jun; 7(6):356-9. PubMed ID: 21502972
    [Abstract] [Full Text] [Related]

  • 24. Kidney angiotensin receptors and their role in renal pathophysiology.
    Sandberg K, Ji H.
    Semin Nephrol; 2000 Sep; 20(5):402-16. PubMed ID: 11022892
    [Abstract] [Full Text] [Related]

  • 25. [Angiotensin II receptor blockers: current status and future prospects].
    Corvol P, Plouin PF.
    Drugs; 2002 Sep; 62 Spec No 1():53-64. PubMed ID: 12036389
    [Abstract] [Full Text] [Related]

  • 26. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
    Haddad G, Amiri F, Garcia R.
    Regul Pept; 1997 Jan 29; 68(2):111-7. PubMed ID: 9110382
    [Abstract] [Full Text] [Related]

  • 27. Therapeutic measures in proteinuric nephropathy.
    Praga M.
    Kidney Int Suppl; 2005 Dec 29; (99):S137-41. PubMed ID: 16336567
    [Abstract] [Full Text] [Related]

  • 28. Direct renin inhibition in a rat model of chronic allograft injury.
    Rusai K, Schmaderer C, Hermans JJ, Lutz J, Heemann U, Baumann M.
    Transplantation; 2011 Nov 15; 92(9):999-1004. PubMed ID: 21956196
    [Abstract] [Full Text] [Related]

  • 29. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
    Athyros VG, Mikhailidis DP, Kakafika AI, Tziomalos K, Karagiannis A.
    Expert Opin Pharmacother; 2007 Apr 15; 8(5):529-35. PubMed ID: 17376010
    [Abstract] [Full Text] [Related]

  • 30. Impact of angiotensin II on the kidney: does an angiotensin II receptor blocker make sense?
    Hollenberg NK.
    Am J Kidney Dis; 2000 Sep 15; 36(3 Suppl 1):S18-23. PubMed ID: 10986155
    [Abstract] [Full Text] [Related]

  • 31. [Renin-angiotensin system in diabetic nephropathy].
    Luño J.
    Nefrologia; 2005 Sep 15; 25 Suppl 2():73-81. PubMed ID: 16050407
    [Abstract] [Full Text] [Related]

  • 32. Local angiotensin II generation in the rat heart: role of renin uptake.
    Müller DN, Fischli W, Clozel JP, Hilgers KF, Bohlender J, Ménard J, Busjahn A, Ganten D, Luft FC.
    Circ Res; 2005 Sep 15; 82(1):13-20. PubMed ID: 9440700
    [Abstract] [Full Text] [Related]

  • 33. Effects of dual blockade of renin-angiotensin system in type 2 diabetes mellitus patients with diabetic nephropathy.
    Krairittichai U, Chaisuvannarat V.
    J Med Assoc Thai; 2009 May 15; 92(5):611-7. PubMed ID: 19459520
    [Abstract] [Full Text] [Related]

  • 34. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
    Luño J, Barrio V, Goicoechea MA, González C, de Vinuesa SG, Gómez F, Bernis C, Espinosa M, Ahijado F, Gómez J, Escalada P.
    Kidney Int Suppl; 2002 Dec 15; (82):S47-52. PubMed ID: 12410855
    [Abstract] [Full Text] [Related]

  • 35. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H, Gilbert RE.
    J Hypertens; 2007 Jan 15; 25(1):25-35. PubMed ID: 17143168
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of the renin-angiotensin-aldosterone system for cerebrorenal protection.
    Lambers Heerspink HJ.
    Contrib Nephrol; 2013 Jan 15; 179():7-14. PubMed ID: 23652444
    [Abstract] [Full Text] [Related]

  • 37. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R.
    Kidney Int; 2001 Jun 15; 59(6):2282-9. PubMed ID: 11380832
    [Abstract] [Full Text] [Related]

  • 38. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 15; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 39. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
    Cantarovich F, Rangoonwala B.
    Int J Clin Pract; 2003 Nov 15; 57(9):801-22. PubMed ID: 14686572
    [Abstract] [Full Text] [Related]

  • 40. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system.
    Iyer SN, Yamada K, Diz DI, Ferrario CM, Chappell MC.
    J Cardiovasc Pharmacol; 2000 Jul 15; 36(1):109-17. PubMed ID: 10892668
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.